This is a preview of subscription content, log in via an institution to check access.
Reference
Sumarsono A, et al. Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries. JAMA Network Open : 28 Feb 2020. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2020.0181
Rights and permissions
About this article
Cite this article
Switch from ER to IR formulations reduces Medicare/Medicaid spending. PharmacoEcon Outcomes News 848, 27 (2020). https://doi.org/10.1007/s40274-020-6640-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6640-9